We are live on ! Find out more
FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

84 hedge funds and large institutions have $164M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 18 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,350% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 4

260% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 5

171% more funds holding

Funds holding: 31 → 84 (+53)

139% more capital invested

Capital invested by funds: $68.7M → $164M (+$95.3M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
84
Holders Change
+53
Holders Change %
+170.97%
% of All Funds
2.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
58
Increased
18
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$17.3M
2
VAM
Visium Asset Management
New York
+$8.55M
3
MMH
Menora Mivtachim Holdings
Israel
+$8.03M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$7.25M
5
BFA
BlackRock Fund Advisors
California
+$6.34M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$10.1M
2
PCM
Pentwater Capital Management
Florida
-$5.31M
3
FAM
Fred Alger Management
New York
-$634K
4
Millennium Management
Millennium Management
New York
-$332K
5
PAM
Panagora Asset Management
Massachusetts
-$230K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Sio Capital Management
New York
$1.65M +$1.78M +161,286 New
AC
27
Ascend Capital
California
$1.6M +$348K +31,449 +25%
Renaissance Technologies
28
Renaissance Technologies
New York
$1.03M +$1.11M +100,800 New
Neuberger Berman Group
29
Neuberger Berman Group
New York
$930K +$1M +90,700 New
MC
30
Menta Capital
California
$891K +$236K +21,350 +33%
OM
31
Opaleye Management
Massachusetts
$871K +$939K +85,000 New
BIM
32
BlackRock Investment Management
Delaware
$834K +$887K +80,247 +7,302%
RFC
33
Russell Frank Company
Washington
$715K +$771K +69,791 New
TCIM
34
TIAA CREF Investment Management
New York
$642K +$693K +62,680 New
Federated Hermes
35
Federated Hermes
Pennsylvania
$615K – – –
PP
36
PDT Partners
New York
$607K +$655K +59,236 New
Deutsche Bank
37
Deutsche Bank
Germany
$532K +$575K +52,009 New
LOAMU
38
Lombard Odier Asset Management (USA)
New York
$530K +$571K +51,658 New
TC
39
TFS Capital
Pennsylvania
$450K +$485K +43,876 New
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$431K +$465K +42,039 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$423K +$457K +41,312 New
Vanguard Group
42
Vanguard Group
Pennsylvania
$409K +$441K +39,865 New
ARTA
43
A.R.T. Advisors
New York
$382K +$265K +24,008 +180%
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$373K +$402K +36,411 New
TA
45
Teachers Advisors
New York
$337K +$363K +32,854 New
Charles Schwab
46
Charles Schwab
California
$332K +$357K +32,336 New
ACP
47
Acuta Capital Partners
California
$308K +$332K +30,000 New
AA
48
ALPS Advisors
Colorado
$306K +$330K +29,846 New
Goldman Sachs
49
Goldman Sachs
New York
$287K +$310K +28,029 New
Geode Capital Management
50
Geode Capital Management
Massachusetts
$286K +$309K +27,932 New
1
2
3 4

FOMX Hedge Fund Activity: Q2 2015 in Review

84 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q2 2015, worth a combined $164M — up 139% from $68.7M a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new FOMX positions and 4 closed out — a net gain of 54 holders — while 18 added to existing stakes and 5 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $17.3M. The largest seller was Jennison Associates, exiting entirely with an estimated $10.1M sold.

  • 84 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q2 2015, up from 31 in Q1 2015.
  • Funds reported $164M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q2 2015, up 139% quarter-over-quarter.
  • 58 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q2 2015 and 4 closed out, a net change of +54 holders.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q2 2015 was Franklin Resources, an estimated $17.3M added.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q2 2015 was Jennison Associates, an estimated $10.1M sold.

Based on aggregated 13F filings for Q2 2015.